Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

NCT01083732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: dabigatran etexilate

Sponsor

Boehringer Ingelheim